CAMP and cancer: •The data describes the synthesis and characterization of newly developed anti-cancer PTR-58-CLB-CAMP peptide drug and demonstrates the viability of HeLa cells with and without the presence of drug-free Triton-X based micellar clusters, that may be relevant for future understanding differences in the interaction of other cell lines with the clusters